Literature DB >> 11675841

Adherence to ATS guidelines for hospitalized patients with community-acquired pneumonia.

D C Malone1, H M Shaban.   

Abstract

OBJECTIVE: To compare outcomes of care and antibiotic utilization for community-acquired pneumonia (CAP) throughout a group of not-for-profit hospitals.
METHODS: A retrospective chart review of patients from community hospitals with a diagnosis of pneumonia at discharge admitted from December 1997 to May 1998. Data were collected based on American Thoracic Society (ATS) criteria.
RESULTS: Medical records of 330 patients were reviewed; mortality was 7%. Using ATS guidelines, 51 (15.5%) patients were not treated with recommended antimicrobial therapy. Of these patients, 14 had nonsevere cases of CAP and 37 cases were severe. Factors found to be associated with in-hospital mortality included nonadherence to ATS guidelines (OR 4.46; 95% CI 1.38 to 14.43), decreased urine output (OR 7.72; 95% CI 1.70 to 35.04), and increasing age (OR 1.06; 95% CI 1.01 to 1.12). Significant predictors of length of stay (LOS) included age, nonadherence to ATS criteria, suspected aspiration, discharge status, low pulse oximetry on admission, decreased urine output, use of vasopressor medications, and interstitial lung disease; More than 80% of patients had at least one culture performed, but only 27.5% of these cultures were positive. The most cpmmonly prescribed antibiotic was cefuroxime injection, representing 25% of the antibiotic orders.
CONCLUSIONS: Patients with CAP treated inconsistently with ATS guidelines had a 4.46-d higher risk of inpatient mortality and had significantly longer LOS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11675841     DOI: 10.1345/aph.10283

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  13 in total

1.  How do we optimize outcomes for patients with severe community-acquired pneumonia?

Authors:  Michael S Niederman
Journal:  Intensive Care Med       Date:  2002-08       Impact factor: 17.440

Review 2.  Measuring adherence to practice guidelines for the management of hypertension: an evaluation of the literature.

Authors:  Jessica L Milchak; Barry L Carter; Paul A James; Gail Ardery
Journal:  Hypertension       Date:  2004-09-20       Impact factor: 10.190

3.  Comparison of two guideline-concordant antimicrobial combinations in elderly patients hospitalized with severe community-acquired pneumonia.

Authors:  Bryan Z Wilson; Antonio Anzueto; Marcos I Restrepo; Mary Jo V Pugh; Eric M Mortensen
Journal:  Crit Care Med       Date:  2012-08       Impact factor: 7.598

4.  Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: a qualitative study.

Authors:  Jeroen A Schouten; Marlies E J L Hulscher; Stephanie Natsch; Bart-Jan Kullberg; Jos W M van der Meer; Richard P T M Grol
Journal:  Qual Saf Health Care       Date:  2007-04

Review 5.  Adherence to guidelines for community-acquired pneumonia: does it decrease cost of care?

Authors:  Patricia D Brown
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

6.  Substitution of cyclophosphamide in the modified BuCy regimen with fludarabine is associated with increased incidence of severe pneumonia: a prospective, randomized study.

Authors:  Dai-hong Liu; Lan-ping Xu; Xiao-hui Zhang; Yu Wang; Chen-hua Yan; Jing-zhi Wang; Feng-rong Wang; Yu-qian Sun; Yu Ji; Yuan-yuan Zhang; Kai-yan Liu; Xiao-jun Huang
Journal:  Int J Hematol       Date:  2013-11-17       Impact factor: 2.490

7.  Mitral regurgitation: determinants of referral for cardiac surgery by Canadian cardiologists.

Authors:  Karine Toledano; Lawrence G Rudski; Thao Huynh; François Béïque; John Sampalis; Jean-François Morin
Journal:  Can J Cardiol       Date:  2007-03-01       Impact factor: 5.223

8.  A clinical pathway for community-acquired pneumonia: an observational cohort study.

Authors:  Christopher R Frei; Allison M Bell; Kristi A Traugott; Terry C Jaso; Kelly R Daniels; Eric M Mortensen; Marcos I Restrepo; Christine U Oramasionwu; Andres D Ruiz; William R Mylchreest; Vanja Sikirica; Monika R Raut; Alan Fisher; Jeff R Schein
Journal:  BMC Infect Dis       Date:  2011-07-06       Impact factor: 3.090

9.  The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia.

Authors:  Eric M Mortensen; Marcos I Restrepo; Antonio Anzueto; Jacqueline Pugh
Journal:  Crit Care       Date:  2005-12-06       Impact factor: 9.097

10.  Cost effectiveness of adherence to IDSA/ATS guidelines in elderly patients hospitalized for Community-Aquired Pneumonia.

Authors:  Michael E Egger; John A Myers; Forest W Arnold; Leigh Ann Pass; Julio A Ramirez; Guy N Brock
Journal:  BMC Med Inform Decis Mak       Date:  2016-03-15       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.